Concepedia

Publication | Open Access

Study Design: Human Leukocyte Antigen Class I Molecule A∗02-Chimeric Antigen Receptor Regulatory T Cells in Renal Transplantation

57

Citations

30

References

2022

Year

Abstract

The STEADFAST study represents the next frontier in adoptive cell therapies. TX200-TR101 holds great potential to prevent immune-mediated graft rejection and induce immunologic tolerance after HLA-A<sup>∗</sup>02-mismatched renal transplantation.

References

YearCitations

Page 1